Skip to content
Health

The feds claim a Malvern firm signed patients up for costly, unnecessary heart monitoring. Now it must pay $14.7 million.

BioTelemetry was accused of violating the False Claims Act from 2014 to 2020. It later was purchased by Royal Philips N.V. for $2.4 billion.

Malvern-based BioTelemetry Inc. and its subsidiary, LifeWatch Services, agreed to pay $14.7 million to resolve allegations that they signed up heart patients for unnecessary services.
Malvern-based BioTelemetry Inc. and its subsidiary, LifeWatch Services, agreed to pay $14.7 million to resolve allegations that they signed up heart patients for unnecessary services.Read moreiStockphoto (custom credit)
    by Tom Avril
    Published